Utilization of the validated Psoriasis Epidemiology Screening Tool to identify signs and symptoms of psoriatic arthritis among those with psoriasis: a cross‐sectional analysis from the US‐based Corrona Psoriasis Registry

Despite increasing awareness of the disease, rates of undiagnosed psoriatic arthritis (PsA) are high in patients with psoriasis (PsO). The validated Psoriasis Epidemiology Screening Tool (PEST) is a five‐item questionnaire developed to help identify PsA at an early stage.

[1]  M. Lebwohl,et al.  Psoriasis: Which therapy for which patient: Psoriasis comorbidities and preferred systemic agents. , 2019, Journal of the American Academy of Dermatology.

[2]  M. Gutierrez,et al.  Dactylitis: A hallmark of psoriatic arthritis. , 2018, Seminars in arthritis and rheumatism.

[3]  M. Gutierrez,et al.  Enthesitis: A hallmark of psoriatic arthritis. , 2018, Seminars in arthritis and rheumatism.

[4]  S. John,et al.  A systematic review of worldwide epidemiology of psoriasis , 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

[5]  T. Nijsten,et al.  Performance of screening tools for psoriatic arthritis: a cross‐sectional study in primary care , 2016, Rheumatology.

[6]  D. Gladman.  Recent advances in understanding and managing psoriatic arthritis , 2016, F1000Research.

[7]  U. Mrowietz,et al.  Sensitivity of the GEPARD Patient Questionnaire to Identify Psoriatic Arthritis in Patients with Psoriasis in Daily Practice: The GEPARD-Life Study , 2016, Dermatology.

[8]  N. McHugh.  Verna Wright Lecture: Psoriatic Arthritis: The Need for Early Intervention , 2015, The Journal of Rheumatology. Supplement.

[9]  D. Gladman.  Clinical Features and Diagnostic Considerations in Psoriatic Arthritis. , 2015, Rheumatic diseases clinics of North America.

[10]  J. Ortonne,et al.  Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis. , 2015, Journal of the American Academy of Dermatology.

[11]  O. FitzGerald,et al.  Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis. , 2015, Annals of the rheumatic diseases.

[12]  B. Tom,et al.  Validation of the Toronto Psoriatic Arthritis Screen Version 2 (ToPAS 2) , 2015, The Journal of Rheumatology.

[13]  D. Gladman,et al.  What have we learned about genetic susceptibility in psoriasis and psoriatic arthritis? , 2015, Current opinion in rheumatology.

[14]  D. Gladman,et al.  Comparative performance of psoriatic arthritis screening tools in patients with psoriasis in European/North American dermatology clinics. , 2014, Journal of the American Academy of Dermatology.

[15]  D. Gladman,et al.  Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics. , 2013, Journal of the American Academy of Dermatology.

[16]  L. Coates,et al.  Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study) , 2013, The British journal of dermatology.

[17]  Rosa Parisi,et al.  Global epidemiology of psoriasis: a systematic review of incidence and prevalence. , 2013, The Journal of investigative dermatology.

[18]  E. Theander,et al.  Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA) , 2013, Annals of the rheumatic diseases.

[19]  G. Shaddick,et al.  Smoking and delay to diagnosis are associated with poorer functional outcome in psoriatic arthritis , 2013, Annals of the rheumatic diseases.

[20]  P. Gisondi,et al.  The early psoriatic arthritis screening questionnaire: a simple and fast method for the identification of arthritis in patients with psoriasis. , 2012, Rheumatology.

[21]  O. FitzGerald,et al.  High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires , 2012, Annals of the rheumatic diseases.

[22]  J. Sampalis,et al.  High Prevalence of Psoriatic Arthritis in a Cohort of Patients with Psoriasis Seen in a Dermatology Practice , 2012, Journal of cutaneous medicine and surgery.

[23]  D. Gladman,et al.  Do patients with psoriatic arthritis who present early fare better than those presenting later in the disease? , 2011, Annals of the rheumatic diseases.

[24]  R. Rafia,et al.  Estimation of health care costs as a function of disease severity in people with psoriatic arthritis in the UK. , 2010, Rheumatology.

[25]  Vinod Chandran,et al.  Soluble biomarkers differentiate patients with psoriatic arthritis from those with psoriasis without arthritis. , 2010, Rheumatology.

[26]  P. Helliwell,et al.  Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: the Psoriasis Epidemiology Screening Tool (PEST) questionnaire. , 2009, Clinical and experimental rheumatology.

[27]  K. Reich,et al.  Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque‐type psoriasis , 2009, The British journal of dermatology.

[28]  B. Tom,et al.  Development and initial validation of a screening questionnaire for psoriatic arthritis: the Toronto Psoriatic Arthritis Screen (ToPAS) , 2008, Annals of the rheumatic diseases.

[29]  A. Qureshi,et al.  The PASE questionnaire: pilot-testing a psoriatic arthritis screening and evaluation tool. , 2007, Journal of the American Academy of Dermatology.

[30]  R. Stern,et al.  Epidemiology of psoriatic arthritis in the population of the United States. , 2005, Journal of the American Academy of Dermatology.

[31]  D. Gladman,et al.  Psoriatic arthritis: epidemiology, clinical features, course, and outcome , 2005, Annals of the rheumatic diseases.

[32]  L Stafford,et al.  A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. , 2003, Rheumatology.

[33]  H. Stenlund,et al.  Inflammatory joint manifestations are prevalent in psoriasis: prevalence study of joint and axial involvement in psoriatic patients, and evaluation of a psoriatic and arthritic questionnaire. , 2002, The Journal of rheumatology.

[34]  Mark Lebwohl,et al.  Psoriasis , 1906, The Lancet.

[35]  E. Maverakis,et al.  Management of psoriatic arthritis: Early diagnosis, monitoring of disease severity and cutting edge therapies. , 2017, Journal of autoimmunity.

[36]  A. Kavanaugh,et al.  Psoriatic arthritis: current therapy and future approaches. , 2015, Rheumatology.